Optimum management of Citrobacter koseri infection

References

• Janda JM, Abbott SL, Cheung WK, Hanson DF. Biochemical identification of citrobacteria in the clinical laboratory. J Clin Microbiol 1994;32:1850-4
   PubMed Web of Science ®Google Scholar
• Hodges GR, Degener CE, Barnes WG. Clinical significance of citrobacter isolates. Am J Clin Pathol 1978;70:37-40
   PubMed Web of Science ®Google Scholar
• Lavigne JP, Defez C, Bouziges N, et al. Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital. Eur J Clin Microbiol Infect Dis 2007;26:439-41
   PubMed Web of Science ®Google Scholar
• Mohanty S, Singhal R, Sood S, et al. Citrobacter infections in a tertiary care hospital in Northern India. J Infect 2007;54:58-64
   PubMed Web of Science ®Google Scholar
• Arens S, Verbist L. Differentiation and susceptibility of Citrobacter isolates from patients in a university hospital. Clin Microbiol Infect 1997;3:53-7
   PubMedGoogle Scholar
• Pepperell C, Kus JV, Gardam MA, et al. Low-virulence Citrobacter species encode resistance to multiple antimicrobials. Antimicrob Agents Chemother 2002;46:3555-60
   PubMed Web of Science ®Google Scholar
• Chiu CH, Peng MY, Wang YC, Chang FY. Endogenous Endophthalmitis Caused by Citrobacter koseri. Am J Med Sci 2009;338:509-10
   PubMed Web of Science ®Google Scholar
• Samonis G, Karageorgopoulos DE, Kofteridis DP, et al. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 2009;28:61-8
   PubMed Web of Science ®Google Scholar
• McPherson C, Gal P, Ransom JL. Treatment of Citrobacter koseri Infection with Ciprofloxacin and Cefotaxime in a Preterm Infant. Ann Pharmacother 2008;42:1134-8
   PubMed Web of Science ®Google Scholar
• Townsend SM, Pollack HA, Gonzalez-Gomez I, et al. Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages. Infect Immun 2003;71:5871-80
   PubMed Web of Science ®Google Scholar
• Jones RN, Jenkins SG, Hoban DJ, et al. In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998. Int J Antimicrob Agents 2000;15:111-18
   PubMed Web of Science ®Google Scholar
• Samonis G, Anaissie E, Elting L, Bodey GP. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period. Eur J Clin Microbiol Infect Dis 1991;10:479-85
   PubMed Web of Science ®Google Scholar
• Gupta N, Yadav A, Choudhary U, Arora DR. Citrobacter bacteremia in a tertiary care hospital. Scand J Infect Dis 2003;35:765-8
   PubMed Web of Science ®Google Scholar
• Kanamori H, Yano H, Hirakata Y, et al. High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2. J Antimicrob Chemother 2011;66(10):2255-62
   PubMed Web of Science ®Google Scholar
• Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Elsevier Inc; PA, USA: 2005. 328-56
   Google Scholar
• Doran TI. The role of Citrobacter in clinical disease of children: review. Clin Infect Dis 1999;28:384-94
   PubMed Web of Science ®Google Scholar
• Pooboni SK, Mathur SK, Dux A, et al. Pneumocephalus in neonatal meningitis: diffuse, necrotizing meningo-encephalitis in Citrobacter meningitis presenting with pneumatosis oculi and pneumocephalus. Pediatr Crit Care Med 2004;5:393-5
   PubMedGoogle Scholar
• Anoop P, Anjay MA, Vincent J, Girija B. Fulminant Citrobacter meningitis with multiple periventricular abscesses in a three-month-old infant. Braz J Infect Dis 2003;7:429-32
   PubMedGoogle Scholar
• Aller SC, Chusid MJ. Citrobacter koseri pneumonia and meningitis in an infant. J Infect 2002;45:65-8
   PubMed Web of Science ®Google Scholar
• Rais-Bahrami K, Short BL. Citrobacter sepsis and severe newborn respiratory failure supported with extracorporeal membrane oxygenation. J Perinatol 2000;20:265-6
   PubMedGoogle Scholar
• Gross RJ, Rowe B. Citrobacter koseri (syn. C. diversus): biotype, serogroup and drug resistance patterns of 517 strains. J Hyg (Lond) 1983;90(2):233-9
   PubMedGoogle Scholar
• Fabrega A, Madurga S, Giralt E, Vila J. Mechanism of action of and resistance to quinolones. Microb Biotechnol 2009;2(1):40-61
   PubMed Web of Science ®Google Scholar
• Hooper DC. Quinolones. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Elsevier Inc; PA, USA: 2005. 451-73
   Google Scholar
• Kluger N, Cartron G, Bessis D, et al. Citrobacter koseri cellulitis during Anti-CD20 monoclonal antibody (Ofatumumab) treatment for B-cell chronic lymphocytic leukaemia. Acta Derm Venereol 2010;90(1):99-100
   PubMed Web of Science ®Google Scholar
• Sawaya FJ, Sawaya JI, Gharzuddine W, et al. Cardiac tamponade caused by polymicrobial gram-negative organisms. Int J Infect Dis 2009;13(6):e483-4
   PubMed Web of Science ®Google Scholar
• Cai T, Giubilei G, Vichi F, et al. A rare case of lethal retroperitoneal abscess caused by Citrobacter koseri. Urol Int 2007;79(4):364-6
   PubMed Web of Science ®Google Scholar
• Lin SY, Ho MW, Yang YF, et al. Abscess caused by Citrobacter koseri infection: three case reports and a literature review. Intern Med 2011;50(12):1333-7
   PubMed Web of Science ®Google Scholar
• Klein NC, Cunha BA. The selection and use of cephalosporins: a review. Adv Ther 1995;12(2):83-101
   PubMed Web of Science ®Google Scholar
• Strehl E, Kees F. Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use. Drugs 2000;59(Suppl 3):9-18
   PubMed Web of Science ®Google Scholar
• Prais D, Nussinovitch M, Harel L, Amir J. Citrobacter koseri (diversus) meningitis in an otherwise healthy adolescent. Scand J Infect Dis 2003;35:4.255-9
   PubMedGoogle Scholar
• Hayati SN, Leong CL, Kumar CS, Lee C. Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis – a case report. Med J Malaysia 2012;67(3):337-9
   PubMedGoogle Scholar
• Fernandes C, Oliveira MC, Jorge MT. A case report of Citrobacter koseri bacteraemia after transfusion of contaminated red cells. Transfus Med 2012;22(6):450-1
   PubMed Web of Science ®Google Scholar
• Kang HM, Chung EJ. Late-onset Citrobacter koseri endophthalmitis with suture exposure after secondary intraocular lens implantation. Korean J Ophthalmol 2011;25(4):285-8
   PubMedGoogle Scholar
• Chen KJ, Sun MH, Hwang YS, et al. Endophthalmitis caused by Citrobacter species. Ocul Immunol Inflamm 2008;16(4):147-53
   PubMed Web of Science ®Google Scholar
• Perilli M, Mugnaioli C, Luzzaro F, et al. Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate. Antimicrob Agents Chemother 2005;49(4):1564-6
   PubMed Web of Science ®Google Scholar
• De Champs C, Chanal C, Sirot D, et al. Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 2004;54(3):634-9
   PubMed Web of Science ®Google Scholar
• Petrella S, Renard M, Ziental-Gelus N, et al. Characterization of the chromosomal class A beta-lactamase CKO from Citrobacter koseri. FEMS Microbiol Lett 2006;254(2):285-92
   PubMed Web of Science ®Google Scholar
• Heritage J, Chambers PA, Tyndall C, Buescher ES. SHV-34: an extended-spectrum beta-lactamase encoded by an epidemic plasmid. J Antimicrob Chemother 2003;52(6):1015-17
   PubMed Web of Science ®Google Scholar
• Mavroidi A, Neonakis I, Liakopoulos A, et al. Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011. Euro Surveill 2011;16(41): pii:19990
   PubMedGoogle Scholar
• Zhanel GG, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs 2007;67(7):1027-52
   PubMed Web of Science ®Google Scholar
• Zhanel GG, Simor AE, Vercaigne L, Mandell L; Canadian Carbapenem Discussion Group. Imipenem and meropenem: comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis 1998;9(4):215-28
   PubMedGoogle Scholar
• Miller AD, Ball AM, Bookstaver PB, et al. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy 2011;31(4):408-23
   PubMed Web of Science ®Google Scholar
• Martínez-Lage JF, Martínez-Lage Azorín L, Almagro MJ, et al. Citrobacter koseri meningitis: a neurosurgical condition? Eur J Paediatr Neurol 2010;14(4):360-3
   PubMed Web of Science ®Google Scholar
• Chowdhry SA, Cohen AR. Citrobacter brain abscesses in neonates: early surgical intervention and review of the literature. Childs Nerv Syst 2012;28(10):1715-22
   PubMed Web of Science ®Google Scholar
• Agrawal D, Mahapatra AK. Vertically acquired neonatal citrobacter brain abscess - case report and review of the literature. J Clin Neurosci 2005;12(2):188-90
   PubMed Web of Science ®Google Scholar
• Marecos CV, Ferreira M, Ferreira MM, Barroso MR. Sepsis, meningitis and cerebral abscesses caused by Citrobacter koseri. BMJ Case Rep 2012;2012: pii bcr1020114941
   Google Scholar
• Besselink MG, Bollen TL, Scheffer RC, et al. Rupture of infected peripancreatic necrosis to the peritoneal cavity with fatal outcome. Pancreas 2007;34(4):477-9
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Takegawa R, Seki M, et al. Pneumorachis associated with multiorgan infection due to Citrobacter koseri. Diagn Microbiol Infect Dis 2013;77(4):370-2
   PubMed Web of Science ®Google Scholar
• Kaufman AM, Watters TS, Henderson RA, et al. Citrobacter koseri as a cause of early periprosthetic infection after primary total hip arthroplasty. J Arthroplasty 2011;26(6):978.e13-16
   Google Scholar
• Castanheira M, Debbia E, Marchese A, Jones RN. Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy). J Chemother 2009;21(1):98-100
   PubMed Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40(9):1333-41
   PubMed Web of Science ®Google Scholar
• Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996;64:4922-7
   PubMed Web of Science ®Google Scholar
• Gross RJ, Rowe B, Easton JA. Neonatal meningitis caused by Citrobacter koseri. J Clin Pathol 1973;26(2):138-9
   PubMed Web of Science ®Google Scholar
• da Silva LM, Nunes Salgado HR. Tigecycline: a review of properties, applications, and analytical methods. Ther Drug Monit 2010;32(3):282-8
   PubMed Web of Science ®Google Scholar
• Mullangi PK, Pankey GA. Tigecycline in critical care. Crit Care Clin 2008;24(2):365-75
   PubMed Web of Science ®Google Scholar
• Petersen PJ, Ruzin A, Tuckman M, Jones CH. In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections. Diagn Microbiol Infect Dis 2010;66(4):407-18
   PubMed Web of Science ®Google Scholar
• Renteria MI, Biedenbach DJ, Bouchillon SK, et al. In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa–Middle East countries: TEST 2007-2012. Available from: http://dx.doi.org/10.1016/j.jgar.2014.03.002
   Google Scholar
• Meyers B, Salvatore M. Tetracyclines and chloramphenicol. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Elsevier Inc; PA, USA: 2005. 356-73
   Google Scholar
• Tang LK, Chen ST, Lui TN. Citrobacter meningitis in adults. Clin Neurol Neurosurg. 1994;96:52-7
   Google Scholar
• Metri BC, Jyothi P, Peerapur BV. Anti-microbial resistance profile of Citrobacter species in a tertiary care hospital of Southern India. Indian J Med Sci 2011;65(10):429-35
   PubMedGoogle Scholar